Bone Health and GLP-1: What You Need to Know

If you are on a GLP-1 medication like Ozempic, Wegovy, or Mounjaro, you have probably thought about how it affects your weight, your blood sugar, your appetite. Bone health probably is not the first thing on your mind. It should be.

Research over the past several years has raised legitimate questions about what GLP-1 agonists do to bone density and fracture risk. The answers are not simple, but they are important enough that anyone on these medications for the long term should understand them.

What the Research Shows

GLP-1 receptor agonists work by mimicking a hormone that regulates blood sugar and appetite. By slowing gastric emptying and acting on brain receptors that control hunger, these medications lead to significant weight loss. That weight loss is a large part of why they have become so widely prescribed.

The problem is that when you lose weight quickly, you tend to lose bone along with it. This is not unique to GLP-1 medications. Any rapid weight loss, whether from bariatric surgery, crash diets, or illness, tends to reduce bone mineral density. The body adapts to a smaller body size, and the bones, which carry less load, remodel themselves accordingly.

What makes GLP-1 medications stand out in this conversation is the combination of fast weight loss plus direct effects on bone metabolism that some studies have suggested.

A 2022 meta-analysis published in the Journal of Bone and Mineral Research looked at data from more than 30 randomized controlled trials involving GLP-1 receptor agonists. The analysis found a statistically significant increase in fracture risk among patients using these medications compared to those using other glucose-lowering drugs or placebo. The risk increase was modest but consistent across several of the studies reviewed.

Another study, published in Frontiers in Endocrinology, examined bone turnover markers in patients taking semaglutide. The researchers observed changes in markers of bone resorption that suggested increased bone loss activity, particularly in the first six months of treatment when weight loss tends to be most rapid.

It is worth noting that some studies have produced mixed results. A 2023 analysis of cardiovascular outcome trials for semaglutide found that while fracture risk appeared elevated in the treatment groups, the absolute number of fractures was small, and some researchers have questioned whether the risk is truly attributable to the medication or to the weight loss itself. The debate is ongoing, and regulatory agencies have not issued black box warnings about bone risk for GLP-1 medications the way they have for other drug classes. But the signal is strong enough that it deserves attention.

Who Is Most at Risk

Not everyone on GLP-1 medications faces the same level of bone risk. Certain factors compound the concern.

Postmenopausal women are at the top of the list. Women after menopause already face accelerated bone loss due to declining estrogen. Add rapid weight loss from a GLP-1 medication on top of that, and the combined effect can be significant. Fracture risk in this group is meaningfully higher than in younger patients or men.

Older adults generally have lower baseline bone density, and the stakes of a fracture in an older adult are higher. A hip fracture in someone over 65 can lead to loss of independence, prolonged hospitalization, and increased mortality. Protecting bone health in this group is not optional.

People with diagnosed osteopenia or osteoporosis before starting GLP-1 therapy need close monitoring. If you already have thinning bones, adding a medication that may accelerate bone loss requires a proactive strategy, not a wait-and-see approach.

Those with a history of eating disorders or severe dietary restriction also warrant caution. GLP-1 medications reduce appetite, which can make it harder to get adequate calcium and protein, both of which are essential for maintaining bone.

If any of those descriptions fit your situation, bring this up with your doctor before or soon after starting a GLP-1 medication. Do not wait for a problem to appear on a bone density scan.

How to Protect Your Bones During GLP-1 Treatment

The good news is that bone loss associated with weight loss is not inevitable, and there are concrete steps you can take to protect yourself.

Calcium and vitamin D are non-negotiable. Calcium is the raw material your bones need to stay dense. Vitamin D is required for your body to absorb that calcium. Most adults need between 1,000 and 1,200 milligrams of calcium per day, and between 800 and 2,000 international units of vitamin D. Food sources include dairy products, leafy greens, fortified plant milks, and fatty fish. Many people, especially those eating less due to reduced appetite on GLP-1 medications, do not get enough from food alone. A supplement can fill that gap.

Tracking your nutrient intake can help you stay consistent. OzemPro lets you log your meals and supplements so you can see whether you are hitting your calcium and vitamin D targets over time. When you have a clear picture of what you are actually eating, it is much easier to spot the gaps before they affect your bones.

Protein matters more than most people realize. Bone is not just calcium. It is a living tissue that requires amino acids to repair and maintain itself. Protein malnutrition, which can occur when appetite is suppressed and food intake drops, is a known risk factor for poor bone outcomes. Aim for at least 0.8 to 1 gram of protein per kilogram of body weight daily. If you are active or older, you may need more.

Weight-bearing exercise signals your bones to stay strong. When you stress your bones through impact or resistance, they respond by remodeling denser and stronger. Walking, jogging, stair climbing, dancing, and resistance training all qualify. You do not need a gym. Bodyweight exercises at home, short walks, and gardening can make a difference if done consistently.

Adding strength training two to three times per week is one of the most evidence-backed interventions for preserving bone density. Lifting weights, using resistance bands, or doing bodyweight exercises like push-ups and squats loads the skeleton in a way that stimulates bone formation.

Get a baseline bone density scan if you are in a high-risk category. A DEXA scan measures your bone mineral density and gives you and your doctor a clear picture of where you stand before or shortly after starting GLP-1 therapy. If your baseline is already low, you and your doctor can design a more aggressive protection plan from the start.

Follow-up scans every one to two years let you track whether your bone density is stable, improving, or declining. OzemPro can help you track symptoms, weight changes, and dietary intake between visits, giving your doctor more data to work with at each appointment.

The Bottom Line

GLP-1 receptor agonists are effective medications that have helped millions of people manage weight and blood sugar. The benefits for many patients are substantial and well-documented. But these medications are not without trade-offs, and bone health is one of them.

The current evidence suggests that fracture risk may increase modestly, particularly in people who lose weight rapidly and in those who already have risk factors like older age, menopause, or low baseline bone density. The mechanism appears to be primarily related to weight loss rather than a direct toxic effect on bone cells, but that distinction matters less than the practical reality: if you are losing bone mass as a result of losing weight, you need to address it.

The steps to protect yourself are straightforward. Get adequate calcium and vitamin D. Prioritize protein. Exercise regularly with weight-bearing and resistance activities. Monitor your bone density if you are at risk. These are not exotic or expensive interventions. They are foundational habits that work.

Your bones carry you through every day of your life. Protecting them while you work on your health goals is not an afterthought. It is part of the plan.

If you want a practical way to track your symptoms, food intake, and progress while on GLP-1 therapy, OzemPro can help you stay organized and share useful data with your doctor at every visit. Track your health in one place and make every appointment count.

If you want a practical way to track your symptoms and progress while on GLP-1 therapy, take a look at what OzemPro offers.